Clinical Trial Update: QYHJ Granules Versus Xeloda in Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing QYHJ Granules to Xeloda in metastatic pancreatic cancer; sponsor is Fudan University; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• QYHJ Granules
• Xeloda (capecitabine)

Snippet

Sponsor: Fudan University | Conditions: Metastatic Pancreatic Cancer | Phase 2 | Status: UNKNOWN